Advertisement

Topics

TherapeuticsMD Presents Positive Phase 3 Data in Two Presentations for TX-001HR at ENDO 2017

16:30 EDT 3 Apr 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
- Results of the Replenish Trial show positive safety and efficacy of TX-001HR as the first potential bio-identical combination treatment for vasomotor symptoms in menopausal women - TherapeuticsMD, Inc. (NYSE MKT: TXMD), an...

Other Sources for this Article

TherapeuticsMD, Inc.
Investor Contact
David DeLucia, 561-961-1900
Director, Investor Relations
David.DeLucia@TherapeuticsMD.com
or
SparkBioComm
Media Contact
Ami Knoefler, 650-739-9952
Ami@SparkBioComm.com

NEXT ARTICLE

More From BioPortfolio on "TherapeuticsMD Presents Positive Phase 3 Data in Two Presentations for TX-001HR at ENDO 2017"

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...